Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1956 2
1963 1
1964 2
1965 2
1984 1
1987 1
1993 1
1995 5
1996 5
1997 1
1998 4
1999 5
2000 6
2001 1
2002 1
2004 2
2006 1
2008 1
2009 2
2010 4
2011 3
2013 1
2014 4
2015 5
2016 4
2017 3
2018 6
2019 6
2020 6
2021 8
2022 8
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Facon T, Dimopoulos MA, Leleu XP, Beksac M, Pour L, Hájek R, Liu Z, Minarik J, Moreau P, Romejko-Jarosinska J, Spicka I, Vorobyev VI, Besemer B, Ishida T, Janowski W, Kalayoglu-Besisik S, Parmar G, Robak P, Zamagni E, Goldschmidt H, Martin TG, Manier S, Mohty M, Oprea C, Brégeault MF, Macé S, Berthou C, Bregman D, Klippel Z, Orlowski RZ; IMROZ Study Group. Facon T, et al. N Engl J Med. 2024 Oct 31;391(17):1597-1609. doi: 10.1056/NEJMoa2400712. Epub 2024 Jun 3. N Engl J Med. 2024. PMID: 38832972 Clinical Trial.
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, Di Bacco A, Hui AM, van de Velde H, Richardson PG; TOURMALINE-MM1 Study Group. Moreau P, et al. N Engl J Med. 2016 Apr 28;374(17):1621-34. doi: 10.1056/NEJMoa1516282. N Engl J Med. 2016. PMID: 27119237 Free article. Clinical Trial.
Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A. Yamada K, et al. Among authors: komeno t. J Infect Dis. 2016 Apr 15;213(8):1253-61. doi: 10.1093/infdis/jiv586. Epub 2015 Dec 9. J Infect Dis. 2016. PMID: 26655300 Free PMC article.
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, Muto H, Tsuyama N, Sato-Otsubo A, Okuno Y, Sakata S, Kamada Y, Nakamoto-Matsubara R, Tran NB, Izutsu K, Sato Y, Ohta Y, Furuta J, Shimizu S, Komeno T, Sato Y, Ito T, Noguchi M, Noguchi E, Sanada M, Chiba K, Tanaka H, Suzukawa K, Nanmoku T, Hasegawa Y, Nureki O, Miyano S, Nakamura N, Takeuchi K, Ogawa S, Chiba S. Sakata-Yanagimoto M, et al. Among authors: komeno t. Nat Genet. 2014 Feb;46(2):171-5. doi: 10.1038/ng.2872. Epub 2014 Jan 12. Nat Genet. 2014. PMID: 24413737
Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
Yamasaki S, Iida H, Yoshida I, Komeno T, Sawamura M, Matsumoto M, Sekiguchi N, Hishita T, Sunami K, Shimomura T, Takatsuki H, Yoshida S, Otsuka M, Kato T, Kuroda Y, Ooyama T, Suzuki Y, Ohshima K, Nagai H, Iwasaki H. Yamasaki S, et al. Among authors: komeno t. Leuk Lymphoma. 2021 Apr;62(4):819-827. doi: 10.1080/10428194.2020.1845336. Epub 2020 Nov 9. Leuk Lymphoma. 2021. PMID: 33167741
100 results